Evidence map›Paper›PMID 27594880›Full record

ArticleGastroenterology research and practice2016

Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome.

Yuksel Seckin, Ali Yigit, Elif Yesilada, Gonca Gulbay, Yasir Furkan Cagin, Harika Gozukara, Yılmaz Bılgıc, Oguzhan Yildirim, Yusuf Turkoz, Zeynep Aksungur

Open access · goldAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association of NOS3 rs1799983 Polymorphism with Cognitive Function in Patients with First Episode Depression.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  4. Article
  5. Article
  6. Protection against Ischemic Heart Disease: A Joint Role for eNOS and the KInternational journal of molecular sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuksel SeckinDepartment of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.ORCID 0000-0003-1403-0705
Ali YigitDepartment of Internal Medicine, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Elif YesiladaDepartment of Medical Biology and Genetics, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Gonca GulbayDepartment of Medical Biology and Genetics, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Yasir Furkan CaginDepartment of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.ORCID 0000-0002-2538-857X
Harika GozukaraDepartment of Biostatistics, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.ORCID 0000-0003-1208-4072
Yılmaz BılgıcDepartment of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Oguzhan YildirimDepartment of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Yusuf TurkozDepartment of Biochemistry, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Zeynep AksungurDepartment of Biochemistry, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Inonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. There are no studies investigating the relationship between endothelial nitric oxide synthase (eNOS) gene polymorphisms and hepatorenal syndrome (HRS). Aim. The purpose of this study is to elucidate whether eNOS gene polymorphisms (G894T and T-786C) play a role in the development of type-2 HRS. Methods. This study was carried out in a group of 92 patients with cirrhosis (44 patients with type-2 HRS and 48 without HRS) and 50 healthy controls. Polymorphisms were determined by polymerase chain reaction (PCR) and melting curve analysis. Results. We did not find any significant difference in allele and genotype distributions of the eNOS -T-786C polymorphism among the groups (p = 0.440). However, the frequency of GT (40.9%) and TT (13.6%) genotypes and mutant allele T (34.1%) for the eNOS G894T polymorphism were significantly higher (p < 0.001 and p < 0.001, resp.) in the HRS group than in both the stable cirrhosis (14.6%, 4.2%, and 11.5%, resp.) and the control (22.0%, 2.0%, and 13.0%, resp.) groups. Conclusion. The occurrence of mutant genotypes (GT/TT) and mutant allele T in eNOS -G894T polymorphisms should be considered as a potential risk factor in cirrhotic patients with HRS.

Identifiers

PMID27594880
PMCPMC4995323
OpenAlexW2499166290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.